Federal Register notice: FDA establishes a public docket to receive information, recommendations, and comments on matters related to its publication o...
Federal Register notice: FDA announces an opportunity for public comment on an information collection extension for the agency guidance entitled Forma...
Federal Register notice: FDA has made available a draft guidance entitled Epidermolysis Bullosa (EB): Developing Drugs for Treatment of Cutaneous Mani...
FDA issues Ortho Dermatologics a complete response letter on its NDA for Duobrii (halobetasol propionate and tazarotene) lotion and its use in treatin...
FDA Review posts the Federal Register notices for the week ending 6/15/2018.
FDA makes available a guidance entitled Epidermolysis Bullosa (EB): Developing Drugs for Treatment of Cutaneous Manifestations.
Federal Register notice: FDA classifies the fluid jet system for prostate tissue removal into Class 2 (special controls).
Federal Register notice: FDA makes available a draft guidance entitled Coronary, Peripheral, and Neurovascular Guidewires Performance Tests and Recom...